SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (1055)3/28/2002 11:27:39 AM
From: keokalani'nui  Read Replies (1) of 2243
 
Bottom was reached in OGSI, that much seems clear. Only other comment about OGSI, which I recently lightened but still hold position, is that vevesca failure will still deal a -33% blow. And with 89% GI events and no placebo control to deal with neuropathy issues, this is a bigger risk then I thought a few months ago. Admittedly, nothing trades near cash without some warts. Hope it succeeds.

Rick, would I be right in assuming you might be out of ogsi before the fate of vevesca is known?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News